“The launch of Leqembi® signifies a pivotal shift in the battle against Alzheimer’s and related dementia disorders. This marks the introduction of the first clinically relevant disease-modifying drug for Alzheimer’s disease. Be Well Memory and Infusion is at the forefront of adopting these groundbreaking therapies, driven by the unparalleled expertise of our clinical team.”
Infusion Therapy
Be Well Memory and Infusion is a unique clinical practice treating individuals with cognitive decline. We offer comprehensive care for patients and families dealing with dementia. Our clinic is among the first to offer the FDA-approved Alzheimer’s treatment called lecanemab or known by its brand name, Leqembi®.
Leqembi® has been shown to slow the cognitive and functional decline in early stages of the disease. Individuals with mild cognitive impairment or mild-stage dementia due to Alzheimer’s disease are eligible to receive Leqembi®.
The service is managed by medical experts including a Be Well geriatrician and neurologist, with a combined 50 years of experience in dealing with cognitive decline.
More details about Leqembi® can be found on the FAQ page.
More details about Leqembi can be found on the FAQ page.